Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAUL SUSTAITA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1801894704
CMS profile
10423560
Location
DONNA, TX

General Payments · PY2021–2024

$1,555.21

  • Reported across 94 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$651.82

41 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $651.82 41

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $141.82 10
PY2022 $249.84 13
PY2023 $511.73 30
PY2024 $651.82 41

Payment records · PY2024 (41)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $24.51 09/12/2024 Food and Beverage Undisputed 01/23/2026 1125282002 CMS
Amgen Inc. $14.37 10/09/2024 Food and Beverage Undisputed 01/23/2026 1117695841 CMS
AstraZeneca Pharmaceuticals LP $68.30 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104487504 CMS
AstraZeneca Pharmaceuticals LP $20.95 03/21/2024 Food and Beverage Undisputed 01/23/2026 1104785824 CMS
AstraZeneca Pharmaceuticals LP $18.22 04/25/2024 Food and Beverage Undisputed 01/23/2026 1105584478 CMS
AstraZeneca Pharmaceuticals LP $17.22 06/13/2024 Food and Beverage Undisputed 01/23/2026 1104657793 CMS
AstraZeneca Pharmaceuticals LP $13.19 07/03/2024 Food and Beverage Undisputed 01/23/2026 1104686594 CMS
AstraZeneca Pharmaceuticals LP $14.72 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104207075 CMS
AstraZeneca Pharmaceuticals LP $13.54 11/11/2024 Food and Beverage Undisputed 01/23/2026 1105750093 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.53 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118161898 CMS
Dexcom, Inc. $21.22 04/19/2024 Food and Beverage Undisputed 01/23/2026 1153383050 CMS
Dexcom, Inc. $24.43 06/07/2024 Food and Beverage Undisputed 01/23/2026 1153383052 CMS
Janssen Pharmaceuticals, Inc $18.83 04/04/2024 Food and Beverage Undisputed 01/23/2026 1078198213 CMS
Lilly USA, LLC $15.89 01/05/2024 Food and Beverage Undisputed 01/23/2026 1135947963 CMS
Lilly USA, LLC $27.50 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135931222 CMS
Lilly USA, LLC $7.54 01/29/2024 Food and Beverage Undisputed 01/23/2026 1135856594 CMS
Lilly USA, LLC $0.76 01/29/2024 Food and Beverage Undisputed 01/23/2026 1135947961 CMS
Lilly USA, LLC $12.02 02/14/2024 Food and Beverage Undisputed 01/23/2026 1135880108 CMS
Lilly USA, LLC $0.63 02/14/2024 Food and Beverage Undisputed 01/23/2026 1135899966 CMS
Lilly USA, LLC $11.69 03/07/2024 Food and Beverage Undisputed 01/23/2026 1135916915 CMS
Lilly USA, LLC $10.99 04/16/2024 Food and Beverage Undisputed 01/23/2026 1135856598 CMS
Lilly USA, LLC $14.36 04/23/2024 Food and Beverage Undisputed 01/23/2026 1135916917 CMS
Lilly USA, LLC $2.58 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135925666 CMS
Lilly USA, LLC $13.67 07/10/2024 Food and Beverage Undisputed 01/23/2026 1135947965 CMS
Lilly USA, LLC $10.41 08/19/2024 Food and Beverage Undisputed 01/23/2026 1135925668 CMS
Lilly USA, LLC $2.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 1135880117 CMS
Lilly USA, LLC $7.97 09/17/2024 Food and Beverage Undisputed 01/23/2026 1135926632 CMS
Lilly USA, LLC $13.15 10/02/2024 Food and Beverage Undisputed 01/23/2026 1135880112 CMS
Lilly USA, LLC $5.07 10/02/2024 Food and Beverage Undisputed 01/23/2026 1135931224 CMS
Lilly USA, LLC $11.70 10/23/2024 Food and Beverage Undisputed 01/23/2026 1135925670 CMS
Lilly USA, LLC $14.51 11/13/2024 Food and Beverage Undisputed 01/23/2026 1135947967 CMS
Merck Sharp & Dohme LLC $17.95 08/28/2024 Food and Beverage Undisputed 01/23/2026 1141839439 CMS
Novo Nordisk Inc $18.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 1100574476 CMS
Novo Nordisk Inc $24.34 03/01/2024 Food and Beverage Undisputed 01/23/2026 1100335090 CMS
Novo Nordisk Inc $17.80 05/18/2024 Food and Beverage Undisputed 01/23/2026 1100473177 CMS
Novo Nordisk Inc $19.58 06/20/2024 Food and Beverage Undisputed 01/23/2026 1100413448 CMS
Novo Nordisk Inc $18.28 08/26/2024 Food and Beverage Undisputed 01/23/2026 1100441239 CMS
Novo Nordisk Inc $7.81 09/20/2024 Food and Beverage Undisputed 01/23/2026 1100641606 CMS
Novo Nordisk Inc $24.95 10/30/2024 Food and Beverage Undisputed 01/23/2026 1100346668 CMS
Novo Nordisk Inc $9.73 11/14/2024 Food and Beverage Undisputed 01/23/2026 1100541172 CMS
Phadia US Inc. $25.46 11/22/2024 Food and Beverage Undisputed 01/23/2026 1067585184 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.